Inflammation meets oxidation: NF-κB as a mediator of initial lesion development in atherosclerosis O Kutuk, H Basaga Trends in molecular medicine 9 (12), 549-557, 2003 | 202 | 2003 |
Alteration of the mitochondrial apoptotic pathway is key to acquired paclitaxel resistance and can be reversed by ABT-737 O Kutuk, A Letai Cancer research 68 (19), 7985-7994, 2008 | 171 | 2008 |
Phytoestrogens in functional foods F Yildiz CRC Press, 2019 | 160 | 2019 |
Regulation of Bcl-2 family proteins by posttranslational modifications A Letai, O Kutuk Current molecular medicine 8 (2), 102-118, 2008 | 143 | 2008 |
Bcl-2 protein family: implications in vascular apoptosis and atherosclerosis O Kutuk, H Basaga Apoptosis 11, 1661-1675, 2006 | 120 | 2006 |
Protein kinases as drug targets in cancer MA Arslan, O Kutuk, H Basaga Current cancer drug targets 6 (7), 623-634, 2006 | 109 | 2006 |
Displacement of Bim by Bmf and Puma rather than increase in Bim level mediates paclitaxel-induced apoptosis in breast cancer cells O Kutuk, A Letai Cell Death & Differentiation 17 (10), 1624-1635, 2010 | 103 | 2010 |
Phosphorylation switches Bax from promoting to inhibiting apoptosis thereby increasing drug resistance J Kale, O Kutuk, GC Brito, TS Andrews, B Leber, A Letai, DW Andrews EMBO reports 19 (9), e45235, 2018 | 85 | 2018 |
High depression symptoms and burnout levels among parents of children with autism spectrum disorders: A multi-center, cross-sectional, case–control study MÖ Kütük, AE Tufan, F Kılıçaslan, G Güler, F Çelik, E Altıntaş, C Gökçen, ... Journal of autism and developmental disorders, 1-14, 2021 | 81 | 2021 |
Aspirin inhibits TNFα-and IL-1-induced NF-κB activation and sensitizes HeLa cells to apoptosis O Kutuk, H Basaga Cytokine 25 (5), 229-237, 2004 | 79 | 2004 |
Small inhibitor of Bcl-2, HA14-1, selectively enhanced the apoptotic effect of cisplatin by modulating Bcl-2 family members in MDA-MB-231 breast cancer cells ED Arisan, O Kutuk, T Tezil, C Bodur, D Telci, H Basaga Breast cancer research and treatment 119, 271-281, 2010 | 73 | 2010 |
Targeting PLK1 overcomes T-DM1 resistance via CDK1-dependent phosphorylation and inactivation of Bcl-2/xL in HER2-positive breast cancer Ö Saatci, S Borgoni, Ö Akbulut, S Durmuş, U Raza, E Eyüpoğlu, C Alkan, ... Oncogene 37 (17), 2251-2269, 2018 | 71 | 2018 |
Apoptosis signalling by 4-hydroxynonenal: a role for JNK–c-Jun/AP-1 pathway O Kutuk, H Basaga Redox Report 12 (1-2), 30-34, 2007 | 71 | 2007 |
Selective targeting of antiapoptotic BCL‐2 proteins in cancer AC Timucin, H Basaga, O Kutuk Medicinal research reviews 39 (1), 146-175, 2019 | 70 | 2019 |
Aspirin Prevents Apoptosis and NF-κB Activation Induced by H2O2 in HeLa Cells O Kutuk, H Basaga Free radical research 37 (12), 1267-1276, 2003 | 65 | 2003 |
Cisplatin overcomes Bcl-2-mediated resistance to apoptosis via preferential engagement of Bak: critical role of Noxa-mediated lipid peroxidation O Kutuk, ED Arisan, T Tezil, MC Shoshan, H Basaga Carcinogenesis 30 (9), 1517-1527, 2009 | 61 | 2009 |
Resveratrol protects against 4-hydroxynonenal-induced apoptosis by blocking JNK and c-JUN/AP-1 signaling O Kutuk, G Poli, H Basaga Toxicological sciences 90 (1), 120-132, 2006 | 59 | 2006 |
Aven blocks DNA damage-induced apoptosis by stabilising Bcl-xL O Kutuk, SG Temel, S Tolunay, H Basaga European journal of cancer 46 (13), 2494-2505, 2010 | 54 | 2010 |
Resveratrol protects against 4‐HNE induced oxidative stress and apoptosis in Swiss 3T3 fibroblasts O Kutuk, M Adli, G Poli, H Basaga Biofactors 20 (1), 1-10, 2004 | 50 | 2004 |
Migraine and associated comorbidities are three times more frequent in children with ADHD and their mothers MO Kutuk, AE Tufan, G Guler, OO Yalin, E Altintas, HG Bag, D Uluduz, ... Brain and Development 40 (10), 857-864, 2018 | 48 | 2018 |